Small-Cell Lung Cancer: The IMpower133 and CASPIAN trials
2 Views
administrator
07/04/23
Expert oncologists consider the IMpower133 (NCT02763579) and CASPIAN trial (NCT03043872) regimens for patients with small-cell lung cancer.
Website: https://www.onclive.com
Twitter: https://twitter.com/OncLive
Facebook: https://www.facebook.com/OncLive/
LinkedIn: https://www.linkedin.com/company/onclive
-
Category
Show more
Facebook Comments
No comments found